Coenzyme Q10 for liver fat in mitochondrial diabetes
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether coenzyme Q10, a natural supplement, can reduce fat in the liver for people with mitochondrial diabetes, a rare form of diabetes caused by a specific gene change. If you have this condition, the study aims to see if the supplement improves liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed mitochondrial gene mutation (m.3243A>G) and diabetes.
- You must be between 18 and 70 years old.
- You cannot have other types of diabetes (type 1 or type 2) caused by other reasons.
- You cannot have other liver diseases like hepatitis or alcohol-related liver damage.
- You cannot have taken coenzyme Q10 or similar supplements in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.
This trial tests whether taking Coenzyme Q10, a natural supplement, can improve heart health markers in people who have or are at high risk for metabolic syndrome. Metabolic syndrome is a group of conditions like high blood sugar, high blood pressure, and belly fat that raise your risk for heart disease and diabetes.
This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.
This trial tests whether a daily supplement called Coenzyme Q10 (CoQ10) can help older adults become more resilient, meaning they can recover better from stress or illness. If you are 65 or older and have some signs of reduced physical function, this study might be a good fit for you.
This trial tests whether a supplement called CoQ10, along with supervised exercise, can improve how the body uses energy in people on chronic dialysis. It may help with muscle function and overall health if your heart and dialysis situation are stable enough.
This trial tests a new pill called QX1206 for people who have both Type 2 diabetes and fatty liver disease (NAFLD). The goal is to see if the medicine is safe and can help improve both conditions.
Hear when a new Mitochondrial Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.